AgraFlora Organics International has completed construction of its pharmaceutical-grade research and development laboratory at its 51,500 square foot GMP edibles manufacturing facility in Winnipeg Manitoba.
"The Company’s 750 square foot turnkey R&D Laboratory boasts a comprehensive suite of made-to-order cannabinoid-testing and product formulation equipment," the team with the company explains. According to them, the lab includes:
- High Performance Liquid Chromatography (“HPLC”);
- Microbiological testing instruments;
- Custom confectionery testing manufacturing and origination/formulation technologies;
- Deposit throughput in excess of 1000 pieces of premium chocolates or gummy edibles per hour;
- Proprietary triple shot depositor capable of producing infused chocolate or liquid filled centre in shell pieces as well as a full vacuum pressure confectionery-cooking system.
"The Company’s Winnipeg Edibles Facility is also equipped with the ability to formulate and mass-produce cannabinoid-infused fruit/vegetable purees which conform to the more rigorous Cannabis 2.0 regulations instilled by the Province of Quebec," they further explain. "This unique product development capability will permit the capture of defendable market share of the edibles topicals and concentrates industry in Canada’s second most populous province. As announced on November 8 2019 AgraFlora intends to initially produce four pectin and/or gelatine based CBD or THC infused gummy SKUs branded with Mesoamerican attributes."
AgraFlora is also in the process of finalizing product formulation contract manufacturing and R&D agreements with various Canadian Licensed Producers. "The Company forecasts that its R&D Laboratory will emerge as a hub for innovation as well as set the industry’s benchmark standard for the industrial-scale production of value-added cannabis products. AgraFlora’s R&D Laboratory will be fully operational upon receipt of Health Canada issued research and development license."
"AgraFlora’s Winnipeg Edibles Facility is equipped with over 30000 square feet of dedicated edibles production space. Once activated the Winnipeg Edibles Facility will be operated by a roster of third generation chocolatiers/confectioners and boasts state-of-the-art manufacturing equipment capable of producing an assortment of both cannabinoid/terpene-infused products for medicinal functional and adult use."
The Winnipeg Edibles Facility is outfitted with fully automated production flows; therefore reducing associated labour costs and optimizing product throughout as follows:
Cooking automation: The Winnipeg Edibles Facility’s confectionery line is powered by a custom made-to-order cooking and mixing system. Recipes are programmed into the confectionery line’s operating system and are queued for production runs. Once the production run is initiated pumping and heating mixing and the cooking of formulations is executed in continuous automated process requiring no human intervention.
Depositing automation: A starchless confectionery mogul corrals the cooked cannabis infused confectionery and deposits the product into silicon moulds with resulting deposit accuracy of greater than 99.5 per cent. Flavours colours and cannabis oil can be substituted during production runs with no downtime required for changeovers. The confectionery is then automatically cooled demoulded sour sanded or oiled and then individually wrapped. From the moment ingredients arrive at the plant to the time products emerge as finished cannabis-infused edibles no manual processes or human intervention are required.
Packaging automation: The Winnipeg Edibles Facility is equipped with industrial high-speed packaging infrastructure that can wrap bag and bottle cannabis edibles at speeds exceeding 15000 packages per hour. Excise stamps are robotically applied to the packages and they are packed into finished cases leveraging automated pick and place systems.
Brandon Boddy Chairman and Chief Executive Officer of AgraFlora stated: “The completion of our pharma-grade R&D Laboratory positions us to secure consistent cash flows as a result of product formulation and contract manufacturing agreements with our peers. We had the corporate foresight to invest in state-of-the-art plant property and equipment prior to the arrival of cannabis 2.0 of which inherent value continues to be evidenced by growing market demand. Armed with this state-of-the-art facility we expect to become the unequivocal leader within the highly lucrative cannabinoid-infused edibles and functional food marketplaces.”
For more information: